Levisetti Matteo 4
4 · Cue Biopharma, Inc. · Filed Feb 22, 2024
Insider Transaction Report
Form 4
Levisetti Matteo
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-20+25,000→ 25,000 totalExercise: $3.36Exp: 2033-01-16→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]On January 17, 2023 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria was deemed satisfied or waived on February 20, 2024 and these shares underlying the option vested in full.